AI Insight
Researchers have developed nanoparticles that serve a dual purpose in treating glioblastoma, a deadly brain cancer. These particles fluoresce to help surgeons visualize cancer cells that would otherwise be invisible during tumor removal, then release therapeutic agents to eliminate any remaining microscopic cancer cells after surgery. In animal studies using mice, this approach prevented tumor recurrence and resulted in 100% survival after 60 days.
Why it matters
Glioblastoma is notoriously difficult to treat because surgeons cannot see all cancer cells during removal, leading to frequent recurrence. This technology could significantly improve surgical outcomes and patient survival rates if it proves safe and effective in human trials.
Understand the Science
Scientists created smart nanoparticles that can both illuminate hidden glioblastoma cells during surgery and destroy microscopic cancer left behind afterward. In mice, the treatment prevented recurrence and led to 100% survival at 60 days, though it has not yet been tested in humans.
Source: Smart nanoparticles light up brain cancer and destroy what surgery misses